Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases—Meeting Report (Part 1)

Bousquet, Jean; Pham‐Thi, N.; Bedbrook, Anna; Agache, Ioana; Annesi‐Maesano, Isabella; Ansotegui, Ignacio J.; Antó, Josep M.; Bachert, Claus; Benveniste, Samuel; Bewick, Mike; Billo, Nils; Bosnic‐Anticevich, Sinthia; Bossé, Isabelle; Brusselle, Guy; Calderón, Moisés A.; Canonica, Giorgio Walter; Caraballo, Luis; Cardona, Victòria; Carriazo, Ana María; Cash, Eugene; Cecchi, Lorenzo; Chu, Derek K.; Colgan, Elaine; Costa, Elı́sio; Cruz, Álvaro A.; Czarlewski, Wienczyslawa; Durham, Stephen R.; Ebisawa, Motohiro; Erhola, Marina; Fauquert, Jean‐Luc; Fokkens, Wytske J.; Fonseca, João; Guldemond, Nick; Iinuma, Tomohisa; Illario, Maddalena; Klimek, Ludger; Kuna, Piotr; Kvedarienė, Violeta; Larenas-Linneman, Desiree; Laune, Daniel; Le, L. T. T.; Lourenço, Olga; Malva, João O.; Mariën, Gert; Menditto, Enrica; Mullol, Joaquim; Münter, Lars; Okamoto, Yoshitaka; Onorato, Gabrielle L.; Papadopoulos, Nikos; Perälä, Maritta; Pfaar, Oliver; Phillips, Abigail; Phillips, Jim; Pinnock, Hilary; Portejoie, F.; Quinones-Delgado, Pablo; Rolland, Christine; Rodts, Ulysse; Samoliński, Bolesław; Sánchez-Borges, Mario; Shamji, Mohamed H.; Somekh, David; Togias, Alkis; Toppila‐Salmi, Sanna; Tsiligianni, Ioanna; Usmani, Omar; Walker, Samantha; Wallace, Dana; Valiulis, Arūnas; Kleij, Rianne van der; Ventura, M. T.; Williams, Siân; Yorgancıoğlu, Arzu; Zuberbier, Torsten

doi:10.21037/jtd.2019.08.64

Cited by 11 publications

(6 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There is also an opportunity to leverage technology. Currently, an EU backed initiative termed as “Next Generation ARIA care pathways” is using digital technology to enable a patient-centered approach in allergy care in order to bridge the existing gap [ 18 ]. Western countries such as the U.S., UK, France, and Japan have brought ARIA into mobile applications such as MACVIA [ 19 ].…”

Section: Discussionmentioning

confidence: 99%

Primary care management of allergic rhinitis: A cross-sectional study in four ASEAN countries

et al. 2020

View full text Add to dashboard Cite

Background: In primary care, general practitioners (GPs) and pharmacists are tasked with the frontline responsibility of identifying and managing allergic rhinitis (AR) patients. There are currently no consolidated data on current treatment practices, patient compliance, and usage of guidelines within Southeast Asian Nations (ASEAN).Objective: To assess the attitudes and practices on AR of GPs and pharmacists in 4 ASEAN countries (Philippines, Indonesia, Thailand, and Malaysia).Methods: A cross-sectional survey of 329 GPs and 548 pharmacists was conducted from May to November 2019. Participants answered a questionnaire focused on their i) current practice in the management of AR, ii) views on patient compliance, iii) understanding and usage of guidelines.Results: Clinical history was the most preferred method to diagnose AR by 95.4% of GPs and 58.8% of pharmacists. Second-generation antihistamines were the most widely available treatment option in GP clinics and pharmacies (94.8% and 97.2%) and correspondingly the most preferred treatment for both mild (90.3%, 76.8%) to moderate-severe rhinitis (90.3%, 78.6%) by GPs and pharmacists, respectively. Loratadine was ranked as the most preferred 2nd generation antihistamines (GP vs pharmacists: 55.3% vs 58.9%). More than 90% of GPs and pharmacists ranked length and efficacy of treatment as important factors that increase patient compliance. Awareness of the ARIA guidelines was high among GPs (80%) and lower among pharmacists (48.4%). However, only 63.3% of GPs and 48.2% of pharmacists knew how to identify AR patients.Conclusion: The survey in the 4 ASEAN countries has identified a need to strengthen the awareness and use of ARIA guidelines among primary care practitioners. Adherence to ARIA guidelines, choosing the appropriate treatment option and prioritizing factors that increase patient compliance may contribute to better management outcomes of AR at the primary care practice.

show abstract

Section: Discussionmentioning

confidence: 99%

Primary care management of allergic rhinitis: A cross-sectional study in four ASEAN countries

et al. 2020

View full text Add to dashboard Cite

show abstract

“…New guidelines for pharmacotherapy and ICPs for allergen-specific immunotherapy (AIT) are currently being developed for allergic rhinitis (AR). Following the Paris meeting, two separate documents were produced [28,29]. The present publication is a summary Fig.…”

Section: Information On the Burden And Costs Of Allergic Diseases Epmentioning

confidence: 99%

ARIA guideline 2019: treatment of allergic rhinitis in the German health system

et al. 2019

Self Cite

View full text Add to dashboard Cite

Background The number of patients affected by allergies is increasing worldwide. The resulting allergic diseases are leading to significant costs for health care and social systems. Integrated care pathways are needed to enable comprehensive care within the national health systems. The ARIA (Allergic Rhinitis and its Impact on Asthma) initiative develops internationally applicable guidelines for allergic respiratory diseases. Methods ARIA serves to improve the care of patients with allergies and chronic respiratory diseases. In collaboration with other international initiatives, national associations and patient organizations in the field of allergies and respiratory diseases, real-life integrated care pathways have been developed for a digitally assisted, integrative, individualized treatment of allergic rhinitis (AR) with comorbid asthma. In the present work, these integrated care pathways have been adapted to the German situation and health system. Results The present ICP (integrated care pathways) guideline covers key areas of the care of AR patients with and without asthma. It includes the views of patients and other healthcare providers. Discussion A comprehensive ICP guideline can reflect real-life care better than traditional guideline models.

show abstract

“…ARIA is constantly evolving and its most recent advance was determined following a meeting of experts/stakeholders in Paris in December 2018 75,76 (Table 6). Three aspects of care pathways were developed during this meeting: (a) patient participation, health literacy and self-care through technology-assisted "patient activation", (b) implementation of care pathways by pharmacists 65 and (c) next-generation guidelines assessing the recommendations of GRADE (Grading of Recommendations, Assessment, Development and Evaluation) guidelines in rhinitis and asthma using RWE 55 and AIT.…”

Section: A Problems Patients Encounter Using An Appmentioning

confidence: 99%

ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

Bousquet

Antó

Bachert

et al. 2020

Allergy

Self Cite

View full text Add to dashboard Cite

show abstract

Next-generation care pathways for allergic rhinitis and asthma multimorbidity: a model for multimorbid non-communicable diseases—Meeting Report (Part 1)

Cited by 11 publications

References 36 publications

Primary care management of allergic rhinitis: A cross-sectional study in four ASEAN countries

Primary care management of allergic rhinitis: A cross-sectional study in four ASEAN countries

ARIA guideline 2019: treatment of allergic rhinitis in the German health system

ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

Contact Info

Product

Resources

About